CCAAT Enhancer Binding Protein Alpha (CEBPA) is one of the recurrently mutated genes in both adult (7–16%) (11, 12) and pediatric (5–15%) AML patients (13–15). Here, CEBPA is linked to acute myeloid leukemia.